首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1477302

糖組學市場，依產品類型、依應用、依最終用戶、依地理位置

Glycomics Market, By Product Type, By Application, By End User, By Geography

出版日期: 2024年03月27日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

糖組學市場預計 2024 年價值為 19.9 億美元，預計到 2031 年將達到 48.2 億美元，2024 年至 2031 年年複合成長率(CAGR) 為 13.5%。

報告範圍		報告詳情
基準年：	2023年	2024 年市場規模：	19.9 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測 2024 年至 2031 年複合年成長率：	13.50%	2031 年價值預測：	48.2 億美元

圖 1.Glycomics 市佔率 (%)（依地區），2024 年

糖組學是對整個醣類（稱為糖組）的大規模研究。糖組學致力於了解生物過程中糖的合成和功能。糖是所有生物的重要組成部分，在蛋白質和脂質中發揮結構或功能作用。糖組學專注於表徵聚醣的結構、功能和相互作用，聚醣是附著在蛋白質和脂質上的糖或糖鏈。了解聚醣非常重要，因為它們影響關鍵的生物機制，包括細胞間通訊、細胞發育、免疫反應和疾病發病機制。質譜和微陣列等分析技術的進步使得高通量糖組分析成為可能，並有望在生物醫學領域中廣泛應用。

市場動態：

全球糖組學市場受到以下因素的推動：對糖基化及其在疾病中的作用的研究不斷增加，政府和私人組織擴大支持糖組學研究，以及聚醣在開發癌症和其他疾病的診斷、生物標記和治療方法中的應用不斷增加。然而，由於聚醣的結構複雜性和缺乏標準化分析方法，市場成長可能會受到醣組分析技術課題的限制。主要機會包括研究機構和公司之間的合作，將基礎糖組學研究轉化為商業生物製藥應用，並將市場擴展到涉及工業產品開發和品質控制的非生物醫學領域。

研究的主要特點：

該報告對全球糖組學市場進行了深入分析，並提供了以 2023 年為基準年的預測期（2024-2031 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數描述了全球糖組學市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球糖組學市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和金融分析師。
利害關係人可以透過用於分析全球糖組學市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
東協
澳洲
韓國
亞太地區其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
北非
中非
南非

第 9 章：競爭格局

公司簡介
- RayBiotech Life, Inc.
- Shimadzu Corporation
- Asparia Glycomics
- Agilent Technologies Inc.
- Thermo Fisher Scientific, Inc.
- Bruker Corporation
- Merck KgaA
- New England Biolabs
- Takara Bio Inc
- Waters Corporation
- Danaher
- Lectenz Bio
- GlycoMimetics, Inc.
- Ludger Ltd.
- GlycoTech Corporation
- Glycosyn LLC
- Glykos, Inc.

第 10 章：分析師觀點

命運之輪
分析師觀點
連貫的機會圖

第 11 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI6796

The glycomics market is estimated to be valued at USD 1.99 Bn in 2024 and is expected to reach USD 4.82 Bn by 2031, growing at a compound annual growth rate (CAGR) of 13.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 1.99 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	13.50%	2031 Value Projection:	US$ 4.82 Bn

Figure 1.Glycomics Market Share (%), By Region, 2024

Glycomics is the large-scale study of the entire complement of sugars, known as the glycome. Glycomics seeks to understand the synthesis and function of sugars in biological processes. Sugars are essential building blocks of all living things and serve structural or functional roles in proteins and lipids. Glycomics focuses on characterizing the structure, function, and interactions of glycans, which are sugars or sugar chains that attach to proteins and lipids. Understanding glycans is important as they influence key biological mechanisms including cell-cell communication, cell development, immune response, and disease pathogenesis. Advancements in analytical technologies, such as mass spectrometry and microarrays, have enabled high-throughput glycomic profiling and hold promise for widespread applications in biomedicine.

Market Dynamics:

The global glycomics market is driven by factors such as increasing research on glycosylation and its roles in diseases, growing initiatives by government and private organizations to support glycomics research, and rising applications of glycans in developing diagnostics, biomarkers, and therapeutics for cancer and other conditions. However, the market growth can be restrained by technical challenges in glycomic analysis due to the structural complexity of glycans and lack of standardized profiling methods. Major opportunities include partnerships between research institutes and companies to translate fundamental glycomics research into commercial biopharmaceutical applications as well as expanding the market into non-biomedical sectors involving industrial product development and quality control.

Key Features of the Study:

This report provides an in-depth analysis of the global glycomics market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global glycomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes RayBiotech Life, Inc., Shimadzu Corporation, Asparia Glycomics, Agilent Technologies Inc., Thermo Fisher Scientific, Inc., Bruker Corporation, Merck KgaA, New England Biolabs, Takara Bio Inc, Waters Corporation, Danaher, Lectenz Bio, GlycoMimetics, Inc., Ludger Ltd., GlycoTech Corporation, Glycosyn LLC, and Glykos, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global glycomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global glycomics market

Market Segmentation

By Product Type:
- Reagents
- Enzymes
- Kits
- Equipment
By Application:
- Diagnostics
- Drug Discovery & Development
- Others
By End User:
- Biopharmaceutical Companies
- Academic & Research Institutes
- CROs
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- RayBiotech Life, Inc.
- Shimadzu Corporation
- Asparia Glycomics
- Agilent Technologies Inc.
- Thermo Fisher Scientific, Inc.
- Bruker Corporation
- Merck KgaA
- New England Biolabs
- Takara Bio Inc
- Waters Corporation
- Danaher
- Lectenz Bio
- GlycoMimetics, Inc.
- Ludger Ltd.
- GlycoTech Corporation
- Glycosyn LLC
- Glykos, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pricing Analysis
PEST Analysis

4. Global Glycomics Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 impact on the market

5. Global Glycomics Market, By Product Type, 2019 - 2031, (USD BN)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Reagents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Enzymes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Kits
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Equipment
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

6. Global Glycomics Market, By Application, 2019 - 2031, (USD BN)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Drug Discovery & Development
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

7. Global Glycomics Market, By End User, 2019 - 2031, (USD BN)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Biopharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
CROs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

8. Global Glycomics Market, By Region, 2019 - 2031, (USD BN)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD BN)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- RayBiotech Life, Inc.*
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Shimadzu Corporation
- Asparia Glycomics
- Agilent Technologies Inc.
- Thermo Fisher Scientific, Inc.
- Bruker Corporation
- Merck KgaA
- New England Biolabs
- Takara Bio Inc
- Waters Corporation
- Danaher
- Lectenz Bio
- GlycoMimetics, Inc.
- Ludger Ltd.
- GlycoTech Corporation
- Glycosyn LLC
- Glykos, Inc.